These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9723444)

  • 21. Effect of FTY720 on rat small bowel transplantation.
    Fujishiro J; Inoue S; Shimizu H; Yoshino H; Murakami T; Kobayashi E
    Transplantation; 2004 Jun; 77(12):1910-1. PubMed ID: 15223918
    [No Abstract]   [Full Text] [Related]  

  • 22. Rescuing acute rejection of rat cardiac allografts with FTY720.
    Chueh SC; Tsai CC; Chiu B; Li YC; Lai MK
    Transplant Proc; 2000 Nov; 32(7):1629-30. PubMed ID: 11119868
    [No Abstract]   [Full Text] [Related]  

  • 23. Donor-specific blood transfusion does not enhance the effect of FTY720 in rat cardiac allotransplantation.
    Antoniou EA; Drayson M; Howie AJ; McMaster P; D'Silva M
    Transplant Proc; 1998 Jun; 30(4):1042-3. PubMed ID: 9636420
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunosuppressive action of FTY720 for renal allograft a rat model.
    Kunikata S; Nagano T; Nishioka T; Akiyama T; Kurita T
    Transplant Proc; 1999; 31(1-2):1157-9. PubMed ID: 10083517
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined therapy of CTLA4Ig-gene transfection with FTY720 administration in rat lung allografts.
    Kita Y; Nogimura H; Ida M; Kageyama Y; Ohi S; Ito Y; Matsushita K; Takahashi T; Suzuki K; Kazui T; Hayashi S; Li X; Suzuki S
    Transplant Proc; 2002 Aug; 34(5):1437-40. PubMed ID: 12176429
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of mycophenolate sodium with or without FTY720 in a DA-to-Lewis rat heart transplantation model.
    Matsumoto Y; Hof RP
    Transplant Proc; 2002 Nov; 34(7):2891-2. PubMed ID: 12431647
    [No Abstract]   [Full Text] [Related]  

  • 27. [Molecular and cellular mechanisms of fingolimod action].
    Nikitin AV
    Antibiot Khimioter; 2013; 58(11-12):38-42. PubMed ID: 24734428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2.
    Paugh SW; Payne SG; Barbour SE; Milstien S; Spiegel S
    FEBS Lett; 2003 Nov; 554(1-2):189-93. PubMed ID: 14596938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination effect of tacrolimus and FTY720 in liver transplantation in rats.
    Tamura A; Li XK; Funeshima N; Enosawa S; Amemiya H; Suzuki S
    Transplant Proc; 1999 Nov; 31(7):2785-6. PubMed ID: 10578290
    [No Abstract]   [Full Text] [Related]  

  • 30. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation.
    Brinkmann V; Pinschewer D; Chiba K; Feng L
    Trends Pharmacol Sci; 2000 Feb; 21(2):49-52. PubMed ID: 10664606
    [No Abstract]   [Full Text] [Related]  

  • 31. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.
    Stepkowski SM; Wang M; Qu X; Yu J; Okamoto M; Tejpal N; Kahan BD
    Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445
    [No Abstract]   [Full Text] [Related]  

  • 32. Prolongation of concordant xenograft survival by a newly developed drug, FTY720.
    Fujiwara I; Nakajima H; Matsuda T; Mizuta N; Yamagishi H; Oka T
    Transplant Proc; 1999 Nov; 31(7):2831-3. PubMed ID: 10578306
    [No Abstract]   [Full Text] [Related]  

  • 33. A new immunosuppressant, FTY720, prolongs limb allograft survival in rats.
    Muramatsu K; Doi K; Shigetomi M; Kido K; Kawai S
    Ann Plast Surg; 1998 Feb; 40(2):160-5. PubMed ID: 9495465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative administration of FTY720 and CTLA4IG in rat heart transplantation.
    Ohba M; Li XK; Kita Y; Tamura A; Enosawa S; Sasakuri S; Ogoshi S; Amemiya H; Suzuki S
    Transplant Proc; 2000 Nov; 32(7):2024-5. PubMed ID: 11120049
    [No Abstract]   [Full Text] [Related]  

  • 35. Beneficial immunosuppressive effect of FTY720 combined with intrathymic injection of splenic cells on rat pancreaticoduodenal allograft.
    Suzuki K; Kazui T; Kawabe A; Li XK; Amemiya H; Suzuki S
    Transplant Proc; 1998 Jun; 30(4):1067-8. PubMed ID: 9636432
    [No Abstract]   [Full Text] [Related]  

  • 36. Tolerance induction with FTY720 and donor-specific blood transfusion: discrepancy between heart transplantation and intestinal transplantation.
    Koshiba T; Ji P; Tanaka K; McMaster P; Van Damme B; Waer M; Pirenne J
    Transplant Proc; 2000 Sep; 32(6):1255-7. PubMed ID: 10995936
    [No Abstract]   [Full Text] [Related]  

  • 37. Future immunosuppressive agents in solid-organ transplantation.
    Gabardi S; Cerio J
    Prog Transplant; 2004 Jun; 14(2):148-56. PubMed ID: 15264459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FTY720: mechanism of action and potential benefit in organ transplantation.
    Brinkmann V
    Yonsei Med J; 2004 Dec; 45(6):991-7. PubMed ID: 15627289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of fingolimod (FTY720) in neuroimmunologic diseases: mechanisms beyond immunomodulation.
    Haghikia A; Gold R
    Am J Pathol; 2010 Jun; 176(6):2599-601. PubMed ID: 20395429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation.
    Xu M; Antoniou EA; Afford SC; Suzuki S; Pirenne J; McMaster P; D'Silva M
    Transplant Proc; 1997 Nov; 29(7):2964-6. PubMed ID: 9365631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.